1. Matching‐adjusted indirect comparison of efficacy and safety of bortezomib, thalidomide, and dexamethasone (VTd) as per label compared with modified VTd dosing schedules in patients with newly diagnosed multiple myeloma who are transplant eligible. Issue 2 (25th August 2020) Authors: Sonneveld, Pieter; Mateos, María‐Victoria; Alegre, Adrian; Facon, Thierry; Hulin, Cyrille; Hashim, Mahmoud; Vincken, Talitha; Kampfenkel, Tobias; Cote, Sarah; He, Jianming; Lam, Annette; Moreau, Philippe Journal: EJHaem Issue: Volume 1:Issue 2(2020) Page Start: 481 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗